BioCentury | Feb 2, 2021
Deals
Feb. 1 Quick Takes: Coherus gets rights to Junshi’s PD-1; plus GSK backs newco Adrestia, a seed for Cellino and more
...toxicity.Sosei Heptares goes beyond GPCRs with Metrion drug discovery dealSosei Group Corp. (Tokyo:4565) partnered with Metrion Biosciences Ltd....
